Health & Science · Coffee preparation and nutrition context

Unfiltered Coffee and Diterpenes: A Contextual Guide

By the CupCura editorial team. How we work

Published · Reviewed

Not reviewed by a clinician. General information, not medical advice.

Coffee contains cafestol and kahweol, two diterpenes with a documented effect on blood lipids. How much reaches your cup depends almost entirely on how you brew.

Key takeaways

  • Moka pots and metal-filter drippers were not measured in the sources cited here; both skip the paper filter.
  • Putting it in proportion: For most people drinking moderate amounts, this is a minor consideration.
  • The practical summary: If your lipids are fine and you drink moderately, brew however you enjoy.
  • Cafestol is the compound doing most of the work here, and it is worth naming because it is what the research measures.
  • Do not conclude espresso is dangerous: servings are small and total exposure is modest.

General information, not medical advice. If it affects a medicine you take or a condition you have, check with a pharmacist or doctor.

The compounds and the mechanism

Cafestol and kahweol occur in coffee oil. Cafestol in particular has been shown to raise LDL cholesterol, and it is among the more potent dietary cholesterol-raising compounds identified.

This is unusually well characterised for a beverage compound: a specific molecule, a measurable effect, and a clear mechanism by which brewing method determines exposure.

Brewing method is the whole story

MethodDiterpene levelWhy
Paper-filtered drip and instantNegligiblePaper traps the oils
EspressoIntermediate (about 1 mg cafestol per cup in one analysis)No paper; small serving
French press (cafetière)High (raised LDL cholesterol 9-14% in a six-month trial at 5-6 strong cups a day)Full immersion, mesh only
Turkish / cezveAmong the highest (about 5.3 mg cafestol per cup)Unfiltered, grounds present
Boiled / ScandinavianHighest (about 7.2 mg cafestol per cup)Unfiltered

Moka pots and metal-filter drippers were not measured in the sources cited here; both skip the paper filter.

Paper is the deciding factor. It is why filtered coffee behaves differently from press coffee in lipid studies, despite being the same bean.

Putting it in proportion

For most people drinking moderate amounts, this is a minor consideration. The effect is dose-dependent, so several French presses a day is a different exposure from one.

It becomes worth attention if you have raised LDL cholesterol, have been advised to manage cardiovascular risk, take lipid-lowering medication, or drink large quantities of unfiltered coffee daily.

In that situation, switching to paper-filtered coffee is a low-cost change that removes most of the exposure without giving up coffee. It is a genuinely useful thing to be able to tell a clinician you have done.

What this is not

It is not a reason to avoid coffee. A meta-analysis of prospective cohort studies found moderate coffee consumption (three to five cups a day) associated with a lower risk of cardiovascular disease, and heavy consumption not associated with higher risk. That is observational, and diterpene content is one factor among many in a complex picture.

It is also not a reason to assume espresso is a problem. Serving sizes are small, and total exposure from a couple of espressos is modest.

The practical summary

If your lipids are fine and you drink moderately, brew however you enjoy. If your lipids are raised, paper filtering is a specific, evidence-based adjustment worth discussing with whoever manages your care — alongside, not instead of, the advice they give you.

Cafestol specifically

Cafestol is the compound doing most of the work here, and it is worth naming because it is what the research measures.

It affects cholesterol through the regulation of bile acid synthesis and cholesterol homeostasis in the liver. Among dietary compounds studied for cholesterol-raising potential it is one of the more potent identified — which sounds alarming stated alone, and is why the amount in your particular cup is the relevant question rather than the potency in isolation.

Bean origin, roast level and variety influence content somewhat. None of them comes close to mattering as much as whether paper is involved.

What not to conclude

Do not conclude espresso is dangerous: servings are small and total exposure is modest.

Do not conclude filtered coffee is therapeutic. Removing cafestol removes a cholesterol-raising input; it does not lower cholesterol.

Do not let it displace the larger drivers of lipid levels — overall diet, physical activity, weight, smoking, genetics and prescribed treatment. This is a small, easy adjustment that belongs alongside those, not in place of them.


Common questions

Is the evidence on unfiltered coffee and diterpenes conclusive?

Rarely. Most beverage research either studies an isolated compound at a dose well above what a cup delivers, or observes populations where the drink is entangled with lifestyle. The honest summary is usually a plausible, partially evidenced mechanism rather than an established clinical effect.

What matters more than which drink I choose?

Serving size, concentration, preparation method, total daily intake and timing. Café portions are frequently several times a nominal cup, and that single factor often explains more variation than beverage type does.

When should I speak to a professional?

If you are pregnant or breastfeeding, managing reflux, a cardiac condition, an anxiety disorder or any diagnosed illness, taking prescription medication, or planning a substantial change to a high habitual intake. This page is educational and is not medical advice.

Sources

Papers and official pages this guide draws on.

  1. Cai L et al. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. European Journal of Clinical Nutrition (2012). doi:10.1038/ejcn.2012.68
  2. Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation (2014). doi:10.1161/CIRCULATIONAHA.113.005925
  3. Gross G, Jaccaud E, Huggett AC. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food and Chemical Toxicology (1997). doi:10.1016/s0278-6915(96)00123-8
  4. Urgert R et al. Comparison of effect of cafetière and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial. BMJ (1996). doi:10.1136/bmj.313.7069.1362